Vaccine Adjuvants Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GSK plc
- SK Bioscience
- Sanofi
- Abbott
- Phibro Animal Health Corporation
- Astrazeneca
- Novavax, Inc.
- Agenus Inc.
- Astellas Pharma Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of vaccine adjuvants is assessed at USD 1.31 billion.
The global vaccine adjuvants market size surpassed USD 1.25 billion in 2025 and is projected to grow at a CAGR of over 5.5%, reaching USD 2.14 billion revenue by 2035.
North America vaccine adjuvants market will dominate more than 35% share by 2035, driven by a large elderly population and increasing prevalence of chronic diseases.
Key players in the market include Pfizer Inc., GSK plc, SK Bioscience, Sanofi, Abbott, Phibro Animal Health Corporation, Astrazeneca, Novavax, Inc., Agenus Inc., Astellas Pharma Inc.
